LSU Health New Orleans and Cumberland Emerging Technologies Inc. (CET) have entered into a collaboration agreement to develop new biomedical products.
With the shared goal of translating research discoveries into commercial products, the parties have agreed to combine their strengths to identify opportunities, based on research at LSU Health New Orleans. Based on the agreement, LSU Health New Orleans will present CET with unique therapeutic discoveries for their consideration to develop. Some of the discoveries could lead to the formation of new biomedical companies which could be located in New Orleans. The potential development pipeline includes therapeutics for cardiovascular diseases, cancer, antifungals, as well as those emerging from drug repurposing.